Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
21 /100
LOW RISK
Score updated Oct 27, 2026

ZVRA — Zevra Therapeutics, Inc. Dilution Risk Tracker

Track ZVRA dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track ZVRA — Get alerts when the score changes →

As of October 27, 2026, Zevra Therapeutics, Inc. (ZVRA) has a DilutionWatch DilutionScore of 21/100, rated LOW dilution risk. Zevra Therapeutics, Inc. has a market capitalization of $587.31M, 59.38M shares outstanding, 149 institutional holders tracked. Stored dilution-related fields include 2.53M outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
46
💰 Cash Runway
0
📊 Float Risk
10
⚠️ Warrant Exposure
15
🔄 Convertible Debt
40

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for ZVRA.
🔔 Track ZVRA — Get forecast alerts →

Market Data

Market Cap$587.31M
Shares Outstanding59.38M
Float54.96M
Cash$151.15M
Debt$1.15M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore21/100DilutionWatch score record
Shares Outstanding59.38MVerified float table or market cache
Public Float54.96MVerified float table or market cache
Market Cap$587.31MMarket data cache
Cash Runway81.4 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding Warrants2.53MSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 2.

Recent SEC source mix: XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

ZVRA SEC Filing Activity — Last 12 Months

Shares outstanding reported by ZVRA on the cover page of its latest 10-K/10-Q: 59.38M as of July 31, 2026.

DilutionWatch recorded no shelf, registration or prospectus documents for ZVRA in the last 12 months. Full filing list on SEC EDGAR →

FormWhat it isFilingsMost recent
8-Kcurrent report (material event)3Jun 05, 2026
10-Kannual report1Mar 09, 2026
10-Qquarterly report2Aug 05, 2026
DEF 14Aproxy statement1Apr 20, 2026
SC 13Gpassive >5% holder filing1Jul 31, 2026
SC 13G/Aamended passive >5% holder filing2Aug 14, 2026
3initial insider ownership8Oct 13, 2026

Institutional Holdings

QoQ: ↑ 27.1% shares (2026Q1 vs prior)
149 institutional holders · 54.20M shares
#1 Woodline Partners LP 6.90M shares
#2 VANGUARD CAPITAL MANAGEMENT LLC 4.94M shares
#3 BlackRock, Inc. 4.46M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest6.23M
Days to Cover7.1
% of Float11.3%
FINRA data as of Oct 15, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-08-05
xbrl XBRL CONVERTIBLE 2022-03-31
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual ZVRA Dilution Snapshot

Zevra Therapeutics, Inc. (ZVRA) has a DilutionScore of 21/100, rated Low dilution risk. Score date: October 27, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

ZVRA's DilutionScore is currently 21/100 (Low risk), with 1 score change tracked over 89 days. The score deteriorated from 25/100 (Low risk).

Period Score Risk Level Duration
Sep 28 – Oct 27, 202621/100LOW30 days
Jul 30 – Sep 27, 202625/100LOW59 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

ZVRA shares outstanding have increased 5.0% from 56.30M (Mar 2026) to 59.12M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 10, 202659.12M54.96M▲ 0.69%
May 01, 202659.11M54.58M▲ 0.23%
Apr 26, 202659.11M54.46M▲ 0.05%
Apr 18, 202658.71M54.43M▲ 0.04%
Mar 28, 202658.71M54.41M▼ 0.14%
Mar 13, 202656.30M54.49M▲ 0.33%
Mar 12, 202656.30M54.31M▲ 4.29%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track ZVRA Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment ZVRA files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking ZVRA — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,566+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for ZVRA
ZVRA FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.